The meglumine salt of 1-(5,6-dichloro-1H-benzo[d]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid (compound (1)) and pharmaceutically acceptable formulations thereof are described. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity.
描述了1-(5,6-二
氯-1H-
苯并[d]
咪唑-2-基)-1H-
吡唑-4-羧酸的美
格胺盐(化合物(1))及其药用可接受的配方。这些化合物可用于制备药物组合物,用于治疗由脯
氨酸羟化酶活性介导的疾病状态、紊乱和症状。